Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.62 USD | +3.56% | -0.76% | +7.82% |
May. 15 | Athira Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 15 | Athira Pharma, Inc. Appoints Javier San Martin, M.D., as Chief Medical Officer | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 100M |
---|---|---|---|---|---|
Net income 2024 * | -108M | Net income 2025 * | -134M | EV / Sales 2024 * | - |
Net cash position 2024 * | 254M | Net cash position 2025 * | 172M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.09
x | P/E ratio 2025 * |
-1.15
x | Employees | 66 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.25% |
Latest transcript on Athira Pharma, Inc.
1 day | +3.56% | ||
1 week | -0.76% | ||
1 month | +28.43% | ||
3 months | -33.50% | ||
6 months | +73.51% | ||
Current year | +7.82% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Litton
CEO | Chief Executive Officer | 56 | 19-07-10 |
Andrew Gengos
DFI | Director of Finance/CFO | 59 | 23-05-17 |
Rachel Lenington
COO | Chief Operating Officer | 51 | 21-06-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Grant Pickering
BRD | Director/Board Member | 56 | 22-01-26 |
John Fluke
BRD | Director/Board Member | 81 | 12-12-31 |
Joseph Edelman
BRD | Director/Board Member | 67 | 20-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +9.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2.62 | +3.56% | 58,853 |
24-05-30 | 2.53 | -0.78% | 107,896 |
24-05-29 | 2.55 | -0.39% | 116,195 |
24-05-28 | 2.56 | -3.03% | 350,567 |
24-05-24 | 2.64 | +3.13% | 97,741 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.82% | 100M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- ATHA Stock